Alexza Pharmaceuticals Inc
ALXA
ALXA was delisted on the 16th of June, 2016.
24 hedge funds and large institutions have $6.22M invested in Alexza Pharmaceuticals Inc in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
12% more capital invested
Capital invested by funds: $5.54M → $6.22M (+$675K)
9% more funds holding
Funds holding: 22 → 24 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$3.04K |
| 2 |
Barclays
London,
United Kingdom
|
+$3.04K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$2.34K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.07K |
| 5 |
Bank of New York Mellon
New York
|
+$688 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$42.1K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$15.1K |
| 3 |
Goldman Sachs
New York
|
-$10.9K |
| 4 |
Citigroup
New York
|
-$6K |
| 5 |
MA
MUFG Americas
New York
|
-$4.49K |
ALXA Hedge Fund Activity: Q3 2015 in Review
24 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q3 2015, worth a combined $6.22M — up 12% from $5.54M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ALXA positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 7 trimmed.
The largest buyer was Northern Trust, adding an estimated $3.04K. The largest seller was Compagnie Lombard Odier SCmA, cutting an estimated $42.1K.
- 24 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q3 2015, up from 22 in Q2 2015.
- Funds reported $6.22M of Alexza Pharmaceuticals Inc stock for Q3 2015, up 12% quarter-over-quarter.
- 4 funds opened new Alexza Pharmaceuticals Inc positions in Q3 2015 and 2 closed out, a net change of +2 holders.
- The largest Alexza Pharmaceuticals Inc buyer in Q3 2015 was Northern Trust, an estimated $3.04K added.
- The largest Alexza Pharmaceuticals Inc seller in Q3 2015 was Compagnie Lombard Odier SCmA, an estimated $42.1K sold.
Based on aggregated 13F filings for Q3 2015.